XML 59 R17.htm IDEA: XBRL DOCUMENT v3.22.1

Accrued Liabilities

3 Months Ended

12 Months Ended

Mar. 31, 2022

Dec. 31, 2021

Accrued Liabilities, Current [Abstract]

Accrued Liabilities

8. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

		March 31, 2022				December 31, 2021
Research and development accrued expenses		$	12,129			$	6,626
Accrued offering costs			—				1,301
Accrued bonus			793				3,429
Other liabilities			1,478				1,824
Total accrued liabilities		$	14,400			$	13,180

9. Accrued Liabilities

Accrued liabilities consist of the following (in thousands):

		December 31,
		2021				2020
Research and development accrued expenses		$	6,626			$	2,060
Accrued offering costs			1,301				576
Accrued bonus			3,429				1,113
Accrued vacation			344				249
Other liabilities			1,480				578
Total accrued liabilities		$	13,180			$	4,576

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration